NLRP3 inhibitors (inflammatory disease)

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

PHTHALAZINE DERIVATIVES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3
EP 4590672 A1申请人: MERCK SHARP & DOHME LLC优先权: 2022
CN
EP
US
WO
4 件公开
5,6 UNSATURATED BICYCLIC HETEROCYLES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3
EP 4719599 A1申请人: MERCK SHARP & DOHME LLC优先权: 2023
CN
EP
US
WO
4 件公开
NLRP3 INFLAMMASOME INHIBITORS AND COMPOSITIONS AND USES THEREOF
EP 4511361 A4申请人: UNIV VIRGINIA COMMONWEALTH优先权: 2022
EP
US
WO
3 件公开
AZAINDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3
US 20250223290 A1申请人: MERCK SHARP & DOHME LLC优先权: 2023
CN
US
WO
3 件公开
INDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3
US 20250195511 A1申请人: MERCK SHARP & DOHME LLC优先权: 2023
CN
US
WO
3 件公开
TRIAZINES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3
EP 4611743 A1申请人: MERCK SHARP & DOHME LLC优先权: 2022
EP
WO
2 件公开
5,6 SATURATED BICYCLIC HETEROCYLES USEFUL AS INHIBITORS OF NOD-LIKE RECEPTOR PROTEIN 3
EP 4719386 A2申请人: MERCK SHARP & DOHME LLC优先权: 2023
EP
WO
2 件公开
Dosing regimen of NLRP3 inhibitors
CN 119816304 A申请人: NOVARTIS AG优先权: 2022
CN
一类1-甲基-2-羧基-3-乙酰苯胺吲哚类化合物及其应用
CN 117069646 B申请人: 中国人民解放军空军军医大学优先权: 2023
CN
COMPOUNDS AS NLRP3 INHIBITORS, AND COMPOSITIONS AND USES THEREOF
WO 2026006510 A1申请人: UNIV VIRGINIA COMMONWEALTH优先权: 2024
WO